{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:42:43Z","timestamp":1795030963637,"version":"4.10.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82101830"],"award-info":[{"award-number":["82101830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200216"],"award-info":[{"award-number":["82200216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202875"],"award-info":[{"award-number":["82202875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303850"],"award-info":[{"award-number":["82303850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473336"],"award-info":[{"award-number":["82473336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY23H160013"],"award-info":[{"award-number":["LY23H160013"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H080001"],"award-info":[{"award-number":["LQ22H080001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ23H160029"],"award-info":[{"award-number":["LQ23H160029"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ24H160017"],"award-info":[{"award-number":["LQ24H160017"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Fund of Hubei Key Laboratory of Precision Radiation Oncology","award":["jzfs015"],"award-info":[{"award-number":["jzfs015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03154-y","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T17:06:58Z","timestamp":1741280818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanwen","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"9","key":"3154_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","volume":"17","author":"H Wang","year":"2018","unstructured":"Wang H, Mooney DJ. Biomaterial-assisted targeted modulation of immune cells in cancer treatment. Nat Mater. 2018;17(9):761\u201372.","journal-title":"Nat Mater"},{"issue":"8","key":"3154_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660\u20139.","journal-title":"Cell Res"},{"issue":"2","key":"3154_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","volume":"72","author":"AL Cheng","year":"2020","unstructured":"Cheng AL, Hsu C, Chan SL, Choo SP, Kudo M. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2020;72(2):307\u201319.","journal-title":"J Hepatol"},{"issue":"7","key":"3154_CR4","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.7150\/thno.54648","volume":"11","author":"X Dai","year":"2021","unstructured":"Dai X, Guo Y, Hu Y, Bao X, Zhu X, Fu Q, et al. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma. Theranostics. 2021;11(7):3489\u2013501.","journal-title":"Theranostics"},{"issue":"1","key":"3154_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","volume":"19","author":"L Kraehenbuehl","year":"2022","unstructured":"Kraehenbuehl L, Weng CH, Eghbali S, Wolchok JD, Merghoub T. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat Rev Clin Oncol. 2022;19(1):37\u201350.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"3154_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH, O\u2019Hara MH. Challenges and opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell. 2020;38(6):788\u2013802.","journal-title":"Cancer Cell"},{"issue":"3","key":"3154_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/anie.201804882","volume":"58","author":"X Duan","year":"2019","unstructured":"Duan X, Chan C, Lin W. Nanoparticle-mediated immunogenic cell death enables and potentiates Cancer Immunotherapy. Angew Chem Int Ed Engl. 2019;58(3):670\u201380.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"22","key":"3154_CR8","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.7150\/thno.46728","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao Y, Luo W, Chen S, Lin F, Zhang X, et al. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells. Theranostics. 2020;10(22):10290\u2013308.","journal-title":"Theranostics"},{"key":"3154_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2022.01.002","volume":"342","author":"Y Geng","year":"2022","unstructured":"Geng Y, Xiang J, Shao S, Tang J, Shen Y. Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy. J Control Release. 2022;342:122\u201333.","journal-title":"J Control Release"},{"issue":"1","key":"3154_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-019-1173-4","volume":"38","author":"X Liu","year":"2019","unstructured":"Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song Y, et al. Celastrol mediates autophagy and apoptosis via the ROS\/JNK and Akt\/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38(1):184.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3154_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu H, Zhao H, Ding C, Jiang D, Zhao Z, Li Y, et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct Target Ther. 2023;8(1):51.","journal-title":"Signal Transduct Target Ther"},{"issue":"35","key":"3154_CR12","doi-asserted-by":"publisher","first-page":"e2404971","DOI":"10.1002\/adma.202404971","volume":"36","author":"S Lu","year":"2024","unstructured":"Lu S, Li Y, Yu Y. Glutathione-scavenging Celastrol-Cu nanoparticles induce self-amplified cuproptosis for Augmented Cancer Immunotherapy. Adv Mater. 2024;36(35):e2404971.","journal-title":"Adv Mater"},{"key":"3154_CR13","doi-asserted-by":"crossref","unstructured":"Wang F, Lai W, Xie D, Zhou M, Wang J, Xu R et al. Nanoparticle-mediated celastrol ER targeting delivery amplify immunogenic cell death in melanoma. J Adv Res. 2024.","DOI":"10.1016\/j.jare.2024.06.011"},{"issue":"8","key":"3154_CR14","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.apsb.2024.04.010","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang Z, Zhuo Y, Zhang Z, Chen R, Liang L, et al. Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy. Acta Pharm Sin B. 2024;14(8):3643\u201360.","journal-title":"Acta Pharm Sin B"},{"key":"3154_CR15","doi-asserted-by":"publisher","first-page":"122723","DOI":"10.1016\/j.biomaterials.2024.122723","volume":"312","author":"L Wu","year":"2025","unstructured":"Wu L, Pi W, Huang X, Yang L, Zhang X, Lu J, et al. Orchestrated metal-coordinated carrier-free celastrol hydrogel intensifies T cell activation and regulates response to immune checkpoint blockade for synergistic chemo-immunotherapy. Biomaterials. 2025;312:122723.","journal-title":"Biomaterials"},{"key":"3154_CR16","doi-asserted-by":"publisher","first-page":"120439","DOI":"10.1016\/j.carbpol.2022.120439","volume":"303","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu X, Wang X, Lin Y, Zheng Y, Xu W, et al. Hepatoma-targeting and reactive oxygen species-responsive chitosan-based polymeric micelles for delivery of celastrol. Carbohydr Polym. 2023;303:120439.","journal-title":"Carbohydr Polym"},{"issue":"12","key":"3154_CR17","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1039\/C9LC00240E","volume":"19","author":"L Kong","year":"2019","unstructured":"Kong L, Chen R, Wang X, Zhao CX, Chen Q, Hai M, et al. Controlled co-precipitation of biocompatible colorant-loaded nanoparticles by microfluidics for natural color drinks. Lab Chip. 2019;19(12):2089\u201395.","journal-title":"Lab Chip"},{"issue":"24","key":"3154_CR18","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.1002\/anie.202001588","volume":"59","author":"Z Sun","year":"2020","unstructured":"Sun Z, Yang C, Wang F, Wu B, Shao B, Li Z, et al. Biocompatible and pH-Responsive Colloidal surfactants with tunable shape for controlled interfacial curvature. Angew Chem Int Ed Engl. 2020;59(24):9365\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3154_CR19","doi-asserted-by":"publisher","first-page":"120604","DOI":"10.1016\/j.biomaterials.2020.120604","volume":"269","author":"N Qiu","year":"2021","unstructured":"Qiu N, Liu Y, Liu Q, Chen Y, Shen L, Hu M, et al. Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials. 2021;269:120604.","journal-title":"Biomaterials"},{"issue":"13","key":"3154_CR20","doi-asserted-by":"publisher","first-page":"e2300175","DOI":"10.1002\/advs.202300175","volume":"10","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Liang G, Guo B, Wang W, Yang C, Chen D, et al. Polyphotosensitizer-based nanoparticles with Michael Addition Acceptors inhibiting GST activity and Cisplatin Deactivation for Enhanced Chemotherapy and photodynamic immunotherapy. Adv Sci (Weinh). 2023;10(13):e2300175.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3154_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12951-023-01950-y","volume":"21","author":"X Tan","year":"2023","unstructured":"Tan X, Wang C, Zhou H, Zhang S, Liu X, Yang X, et al. Bioactive fatty acid analog-derived hybrid nanoparticles confer antibody-independent chemo-immunotherapy against carcinoma. J Nanobiotechnol. 2023;21(1):183.","journal-title":"J Nanobiotechnol"},{"key":"3154_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2021.02.020","volume":"332","author":"X Liu","year":"2021","unstructured":"Liu X, Feng Y, Xu J, Shi Y, Yang J, Zhang R, et al. Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade. J Control Release. 2021;332:194\u2013209.","journal-title":"J Control Release"},{"issue":"408","key":"3154_CR23","doi-asserted-by":"publisher","first-page":"eaan4220","DOI":"10.1126\/scitranslmed.aan4220","volume":"9","author":"MC Brown","year":"2017","unstructured":"Brown MC, Holl EK, Boczkowski D, Dobrikova E, Mosaheb M, Chandramohan V, et al. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. Sci Transl Med. 2017;9(408):eaan4220.","journal-title":"Sci Transl Med"},{"key":"3154_CR24","doi-asserted-by":"publisher","first-page":"122463","DOI":"10.1016\/j.biomaterials.2023.122463","volume":"305","author":"Y Jin","year":"2024","unstructured":"Jin Y, Huang Y, Ren H, Huang H, Lai C, Wang W, et al. Nano-enhanced immunotherapy: targeting the immunosuppressive tumor microenvironment. Biomaterials. 2024;305:122463.","journal-title":"Biomaterials"},{"issue":"11","key":"3154_CR25","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1039\/D1CS00343G","volume":"51","author":"Y Ju","year":"2022","unstructured":"Ju Y, Liao H, Richardson JJ, Guo J, Caruso F. Nanostructured particles assembled from natural building blocks for advanced therapies. Chem Soc Rev. 2022;51(11):4287\u2013336.","journal-title":"Chem Soc Rev"},{"issue":"3","key":"3154_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ccell.2022.01.006","volume":"40","author":"MP Vincent","year":"2022","unstructured":"Vincent MP, Navidzadeh JO, Bobbala S, Scott EA. Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy. Cancer Cell. 2022;40(3):255\u201376.","journal-title":"Cancer Cell"},{"issue":"6","key":"3154_CR27","first-page":"20230061","volume":"3","author":"J Yang","year":"2023","unstructured":"Yang J, He Y, Zhang M, Liang C, Li T, Ji T, et al. Programmed initiation and enhancement of cGAS\/STING pathway for tumour immunotherapy via tailor-designed ZnFe(2)O(4)-based nanosystem. Explor (Beijing). 2023;3(6):20230061.","journal-title":"Explor (Beijing)"},{"issue":"2","key":"3154_CR28","first-page":"216","volume":"2","author":"B Feng","year":"2023","unstructured":"Feng B, Lu X, Zhang G, Zhao L, Mei D. STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma. Acta Materia Med. 2023;2(2):216\u201327.","journal-title":"Acta Materia Med"},{"issue":"28","key":"3154_CR29","doi-asserted-by":"publisher","first-page":"eadn0960","DOI":"10.1126\/sciadv.adn0960","volume":"10","author":"H Li","year":"2024","unstructured":"Li H, Li Y, Zhang L, Wang N, Lu D, Tang D, et al. Prodrug-inspired adenosine triphosphate-activatable celastrol-Fe(III) chelate for cancer therapy. Sci Adv. 2024;10(28):eadn0960.","journal-title":"Sci Adv"},{"key":"3154_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","volume":"521","author":"HY Lim","year":"2021","unstructured":"Lim HY, Ong PS, Wang L, Goel A, Ding L, Li-Ann Wong A, et al. Celastrol in cancer therapy: recent developments, challenges and prospects. Cancer Lett. 2021;521:252\u201367.","journal-title":"Cancer Lett"},{"key":"3154_CR31","doi-asserted-by":"publisher","first-page":"216461","DOI":"10.1016\/j.canlet.2023.216461","volume":"579","author":"B Niu","year":"2023","unstructured":"Niu B, Wu Y, Zhou M, Lin R, Ge P, Chen X, et al. Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts. Cancer Lett. 2023;579:216461.","journal-title":"Cancer Lett"},{"issue":"1","key":"3154_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H, et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2019;14(1):89\u201397.","journal-title":"Nat Nanotechnol"},{"issue":"35","key":"3154_CR33","doi-asserted-by":"publisher","first-page":"e2303542","DOI":"10.1002\/adma.202303542","volume":"35","author":"X Dai","year":"2023","unstructured":"Dai X, Zhang J, Bao X, Guo Y, Jin Y, Yang C, et al. Induction of Tumor ferroptosis-dependent immunity via an Injectable Attractive Pickering Emulsion Gel. Adv Mater. 2023;35(35):e2303542.","journal-title":"Adv Mater"},{"issue":"28","key":"3154_CR34","doi-asserted-by":"publisher","first-page":"e1801527","DOI":"10.1002\/adma.201801527","volume":"30","author":"S Yu","year":"2018","unstructured":"Yu S, Wang C, Yu J, Wang J, Lu Y, Zhang Y, et al. Injectable Bioresponsive Gel Depot for enhanced Immune Checkpoint Blockade. Adv Mater. 2018;30(28):e1801527.","journal-title":"Adv Mater"},{"key":"3154_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.actbio.2024.08.055","volume":"188","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wu H, Wang Y, Rao Y, Yan J, Ran B, et al. Enhancing melanoma therapy by modulating the immunosuppressive microenvironment with an MMP-2 sensitive and nHA\/GNE co-encapsulated hydrogel. Acta Biomater. 2024;188:79\u201392.","journal-title":"Acta Biomater"},{"issue":"2","key":"3154_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1001\/jamaoncol.2019.5409","volume":"6","author":"A Gupta","year":"2020","unstructured":"Gupta A, Sedhom R, Beg MS. Ascites, or Fluid in the Belly, in patients with Cancer. JAMA Oncol. 2020;6(2):308.","journal-title":"JAMA Oncol"},{"key":"3154_CR37","doi-asserted-by":"publisher","first-page":"104237","DOI":"10.1016\/j.critrevonc.2023.104237","volume":"194","author":"Y Wang","year":"2024","unstructured":"Wang Y, Sun Y, Li X, Yu X, Zhang K, Liu J, et al. Progress in the treatment of malignant ascites. Crit Rev Oncol Hematol. 2024;194:104237.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"3154_CR38","doi-asserted-by":"publisher","first-page":"e004749","DOI":"10.1136\/jitc-2022-004749","volume":"10","author":"DKA Chia","year":"2022","unstructured":"Chia DKA, Gwee YX, Sundar R. Resistance to systemic immune checkpoint inhibition in the peritoneal niche. J Immunother Cancer. 2022;10(6):e004749.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"3154_CR39","doi-asserted-by":"publisher","first-page":"e004001","DOI":"10.1136\/jitc-2021-004001","volume":"10","author":"G Fuca","year":"2022","unstructured":"Fuca G, Cohen R, Lonardi S, Shitara K, Elez ME, Fakih M, et al. Ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers. J Immunother Cancer. 2022;10(2):e004001.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"3154_CR40","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1021\/acsami.2c19769","volume":"15","author":"A Huang","year":"2023","unstructured":"Huang A, Guo F, Yu Z, Liu P, Dong S, Zhang Y, et al. Engineered apoptosis-bioinspired nanoparticles initiate Immune Cascade for Cancer Immunotherapy of Malignant ascites. ACS Appl Mater Interfaces. 2023;15(8):10371\u201382.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3154_CR41","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","volume":"10","author":"P Liu","year":"2019","unstructured":"Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, et al. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nat Commun. 2019;10(1):1486.","journal-title":"Nat Commun"},{"key":"3154_CR42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jconrel.2021.02.011","volume":"332","author":"L Li","year":"2021","unstructured":"Li L, Wang J, Radford DC, Kopecek J, Yang J. Combination treatment with immunogenic and anti-PD-L1 polymer-drug conjugates of advanced tumors in a transgenic MMTV-PyMT mouse model of breast cancer. J Control Release. 2021;332:652\u20139.","journal-title":"J Control Release"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03154-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T17:07:05Z","timestamp":1741280825000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03154-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3154"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03154-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Animal Experimental Ethical Inspection of the Institutional Animal Care and Use Committee and Zhejiang of Laboratory Animals with the approval number ZJCLA-IACUC-20010637.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}